| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 303.435 | 87 |
| GSM780708 | Untreated after 4 days (C2_1) | 233.669 | 85 |
| GSM780709 | Untreated after 4 days (C3_1) | 246.809 | 86 |
| GSM780719 | Untreated after 4 days (C1_2) | 306.476 | 88 |
| GSM780720 | Untreated after 4 days (C2_2) | 268.371 | 86 |
| GSM780721 | Untreated after 4 days (C3_2) | 263.427 | 86 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 481.148 | 91 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 239.853 | 85 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 756.895 | 94 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 498.166 | 92 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 249.846 | 86 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 828.888 | 95 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 201.407 | 84 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 272.598 | 87 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 302.986 | 87 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 250.682 | 86 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 282.862 | 87 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 252.832 | 86 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 216.596 | 84 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 203.405 | 84 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 316.865 | 88 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 223.011 | 85 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 267.72 | 86 |